Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.
Ashley Gholston Fowler provides healthcare regulatory and transactional counsel as it relates to mergers and acquisitions, compliance and operational matters.
Ashley earned her law degree with a Health Law Certificate from Belmont University College of Law and a B.S. in biology from the University of Alabama at Birmingham. After completing her undergraduate studies, Ashley attended medical school for several years and also directed an after-school program at the PENCIL Foundation.
Representation of Shore Capital’s portfolio company Senta Partners, a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region, in its partnership with Northeast Georgia ENT, a large otolaryngology practice in Northeastern Georgia.
We represented Shore Capital Partners portfolio company, SENTA Partners, a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region, in its affiliation with, Asthma & Allergy Specialists, a group of highly skilled pediatric pulmonologists and board-certified Asthma, Allergy and Immunologists in North Carolina. Terms of the transaction were not disclosed.
Representation of Shore Capital Partners portfolio company, SENTA Partners, a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region, in its acquisition of Advanced ENT & Allergy, a leading ENT and Allergy practice in Kentucky and Indiana. Terms of the transaction were not disclosed.
We represented Havencrest Capital Management, a Dallas-based, private equity fund manager specializing in the healthcare industry, in its acquisition of Tekton, a clinical trial site network with 23 sites across Texas, Colorado, Georgia, Kansas, and Oklahoma. Terms of the transaction were not disclosed.
Representation of SENTA partners, a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region, in its acquisition of Reston Ear Nose and Throat, P.C., a leading adult and pediatric otolaryngology center in Northern Virginia. Terms of the transaction were not disclosed.
Counsel to Shore Capital Partner’s OPMH/Transformations platform, through its MSO Northeast Health Services, L.L.C., in its acquisition of the non-clinical assets of, and entered into a management services arrangement with, Psychiatric Care Systems, P.C. Terms of the transaction were not disclosed.
Representation of SENTA partners, a portfolio company of Shore Capital Partners and a leading community of the finest ENT and Allergy/Immunology specialists in the Southern region, in its acquisition of South Carolina ENT, Allergy & Sleep Medicine, P.A., an ear nose and throat practice in South Carolina. Terms of the transaction were not disclosed.
Representation of Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by Shore Capital Partners, in its acquisition of ENT Carolina, P.A., a leading group practice of ENT and Allergy in the Charlotte community. Terms of the transaction were not disclosed.
